司美格鲁肽与人血清白蛋白相互作用模式及亲和力OA
Study on the Interaction Mode and Affinity between Semaglutide and Human Serum Albumin
目的 该研究综合运用计算机模拟分子对接技术与表面等离子共振(SPR)技术,深入探究司美格鲁肽与人血白蛋白的相互作用.方法 借助 Autodock Vina 和 Discovery Studio(DS)2 种软件开展分子对接模拟,从结构层面揭示司美格鲁肽与人血白蛋白的相互作用模式,明确结合位点及关键氨基酸残基.同时,针对传统 SPR 分析方法的局限性,创新性地提出以司美格鲁肽为偶联配体、单循环动力学作为分析方法的改进方案.结果 Autodock Vina 和 Discovery Studio 模拟对接中,司美格鲁肽与人血白蛋白(HSA)的亲和分数分别为-66.88和-24.24 kJ•mol-1,表明二者存在较强的相互作用.并且在 SPR 改进分析方式中,多循环动力学和单循环动力学试验结果传感图均符合动力学模型,采用 1∶1 Langmuir 动力学模型拟合曲线,两个厂家的司美格鲁肽与 HSA 结合亲和力差异无统计学意义.结论 改进后的 SPR 分析方法能够更准确地测定结合亲和力,与分子模拟结果高度契合,为胰高血糖素样肽-1(GLP-1)类似物的研发提供了新的技术手段和理论依据.
Objective This study comprehensively employed computer simulation molecular docking technology and surface plasmon resonance(SPR)technology to investigate the interaction between semaglutide and human serum albumin(HSA).Methods Molecular docking simulations were conducted using two software tools,Autodock Vina and Discovery Studio(DS),to reveal the structural interaction pattern between semaglutide and HSA,identifying the binding site and key amino acid residues.Additionally,to address the limitations of traditional SPR analysis methods,an innovative approach was proposed,using semaglutide as the conjugated ligand and single-cycle kinetics as the analytical method.Results In the Autodock Vina and Discovery Studio docking simulations,the affinity scores between semaglutide and HSA were-66.88 and-24.24 kJ•mol-1,respectively,indicating strong interactions.Furthermore,in the SPR-based analysis,the sensor plots from multi-cycle kinetics and single-cycle kinetics experiments both aligned with the kinetic model.Using the 1∶1 Langmuir kinetic model to fit the curves,no significant difference was observed in the binding affinity of semaglutide to HSA between the two manufacturers.Conclusions The improved SPR analysis method can measure the binding affinity more accurately and is highly consistent with the results of molecular simulation.It provides a new technical means and theoretical basis for the development of GLP-1 analogues.
苏雯;王恩娜;方帷;吴凡;程宾
云南省食品药品监督检验研究院,工业和信息化部产业技术基础公共服务平台,药品监管科学全国重点实验室,昆明 650106云南省食品药品监督检验研究院,工业和信息化部产业技术基础公共服务平台,药品监管科学全国重点实验室,昆明 650106云南省食品药品监督检验研究院,工业和信息化部产业技术基础公共服务平台,药品监管科学全国重点实验室,昆明 650106云南省食品药品监督检验研究院,工业和信息化部产业技术基础公共服务平台,药品监管科学全国重点实验室,昆明 650106云南省食品药品监督检验研究院,工业和信息化部产业技术基础公共服务平台,药品监管科学全国重点实验室,昆明 650106
医药卫生
司美格鲁肽人血清白蛋白分子对接表面等离子共振技术
SemaglutideHuman serum albuminMolecular dockingSurface plasmon resonance technology
《医药导报》 2026 (4)
596-602,7
药品监管科学全国重点实验室课题(2025SKLDRS0312).
评论